2023
English BC, Savage HP, Mahan SP, Diaz-Ochoa VE, Young BM, Abuaita BH, Sule G, Knight JS, O'Riordan MX, Bäumler AJ, Tsolis RM
The IRE1a-XBP1 Signaling Axis Promotes Glycolytic Reprogramming in Response to Inflammatory Stimuli.

2023
Smith FL, Savage HP, Luo Z, Tipton CM, Lee FE, Apostol AC, Beaudin AE, Lopez DA, Jensen I, Keller S, Baumgarth N
B-1 plasma cells require non-cognate CD4 T cell help to generate a unique repertoire of natural IgM

2022
Liou MJ, Miller BM, Litvak Y, Nguyen H, Natwick DE, Savage HP, Rixon JA, Mahan SP, Hiyoshi H, Rogers AWL, Velazquez EM, Butler BP, Collins SR, McSorley SJ, Harshey RM, Byndloss MX, Simon SI, Bäumler AJ
Host cells subdivide nutrient niches into discrete biogeographical microhabitats for gut microbes

2021
Cevallos SA, Lee JY, Velazquez EM, Foegeding NJ, Shelton CD, Tiffany CR, Parry BH, Stull-Lane AR, Olsan EE, Savage HP, Nguyen H, Ghanaat SS, Byndloss AJ, Agu IO, Tsolis RM, Byndloss MX, Bäumler AJ
5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-? Signaling in the Intestinal Epithelium

2019
Kreuk LS, Koch MA, Slayden LC, Lind NA, Chu S, Savage HP, Kantor AB, Baumgarth N, Barton GM
B cell receptor and Toll-like receptor signaling coordinate to control distinct B-1 responses to both self and the microbiota

2019
Savage HP, Kläsener K, Smith FL, Luo Z, Reth M, Baumgarth N
TLR induces reorganization of the IgM-BCR complex regulating murine B-1 cell responses to infections

2018
Ordoñez C, Savage HP, Tarajia M, Rivera R, Weeks-Galindo C, Sambrano D, Riley L, Fernandez PL, Baumgarth N, Goodridge A
Both B-1a and B-1b cells exposed to Mycobacterium tuberculosis lipids differentiate into IgM antibody-secreting cells

2017
Savage HP, Yenson VM, Sawhney SS, Mousseau BJ, Lund FE, Baumgarth N
Blimp-1-dependent and -independent natural antibody production by B-1 and B-1-derived plasma cells

2015
Savage HP, Baumgarth N
Characteristics of natural antibody-secreting cells

2014
DePillis LG, Savage HP, Radunskaya AE
Mathematical Model of Colorectal Cancer with Monoclonal Antibody Treatments